Suramin sodium. CI 1003, Metaret, suramin, suramin hexasodium.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000188:drug therapy*; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D013498:Suramin / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013498:Suramin